Læknaneminn

Ataaseq assigiiaat ilaat

Læknaneminn - 01.04.1997, Qupperneq 118

Læknaneminn - 01.04.1997, Qupperneq 118
Peter Duesberg and David Rasnick antivirals since I’ve been following them since the very beginning... They’ve watched all of their friends go on the antiretroviral bandwagon and die, so they’ve chose to remain naive to therapy. More and more, however, are now succumbing to pressure that protease inhibitors are it ... We are in the middle of the honey- moon period, and whether or not this is going to be an enduring marriage is unclear to me at this time, so I’m advising my patients if they still have time, to wait.” 180 Unknowingly the vast majority of HlV-positives are long-term survivors! Worldwide, they number 17 mil- lion, including 1 million HlV-positive, healthy Americans and 0.5 million HlV-positive, healthy Europeans 269, 27°. Most of these must have been HIV- positive for at least 10 years now because the numbers of the HlV-positive Americans and Europeans have not changed during the period 1984 to 1988 when the epi- demic of HlV-testing began in the respective countries 26'29 (Fig.l). Since no more than 6% of the 17 million people worldwide with antibodies to HIV have developed AIDS over the last 7 to 10 years, the risk of AIDS to an HlV-carrier is less than 1% peryear 27°. However, even this low figure is not corrected for the normal occurence of the 30 AIDS-defming diseases in HIV- free controls. There is not a single controlled study in the vast AIDS literature proving that HlV-positive peo- ple who are not drug users have a higher morbidity or mortality than HlV-free controls n’225. (See 7., Tables 4 and 5) To save the reputation of the “deadly virus” in the face of long-term survivors, orthodox HIV researchers have already posted warnings that “regrettably ... the proportion of individuals who might demonstrate such a benign course is very small” 271. Others have postu- lated rare HIV attenuating mutations without provid- ing functional evidence 248,25°. Gallo et al. went even further by postulating human mutants, who fall victim of HIV because they lack “major HlV-suppressive fac- tors” 272. According to Gallo’s hypothesis most American homosexuals, hemophiliacs and intravenous drug users are mutants! 2) Drug users developing AIDSprior to HIV infection. Prospective studies have demonstrated that the T-cells of male homosexuals using psychoactive drugs and sex- ual stimulants may decline prior to infection with HIV. For example, the T-cells of 37 homosexual men from San Francisco declined steadily prior to HIV infection for 1.5 years from over 1200 to below 800 per pl 273. Some even had fewer than 500 T-cells 1.5 years before seroconversion 274. Although recreational drug use was not mentioned in these articles, other studies of the same cohort of homosexual men from San Francisco described extensive use of recreational drugs including nitrites 80, 112, 1K l45,275. Likewise, 33 HlV-free male homosexuals from Vancouver, Canada, had "acquired” immunodeficiency prior to HIV infection 276. Again this study did not mention drug use, but in other arti- cles the authors reported that all men of this cohort had used nitrites, cocaine and amphetamines 4a-,K-2T7. The MAC study reported that about 450 (16% of 2795) HlV-free, homosexual American men from Chicago, Baltimore, Pittsburgh and Los Angeles had acquired immunodeficiency, having less than 600 T- cells per pl, prior to HIV infection 103. Many HIV- positive and -negative men of this cohort had essential- ly the same degree of lymphadenopathy: "Although seropositive men had a significantly higher mean num- ber of involved lymphnode groups than seronegative men (5.7 compared to 4.5 nodes, p<0.005), the numerical difference in the means is not striking” 27S. According to previous studies on this cohort, 71% of these men had used -based on self reporting- nitrite inhalants, in addition to other drugs 278; 83% had used one drug, and 60% had used two or more drugs dur- ing sex in the previous six months 279. Indeed, not a single prospective study of male homo- sexual cohorts at risk for AIDS ever measured drug use directly. Instead, each relied only on self reporting, using questionnaires that focused on recent use of a few selective drugs 31-48,229,275 (see 7.). By contrast, all HIV tests were based on experimental methods that maxi- mize positivity such as antibodies against the virus instead of the virus itself, or amplification of fragments of viral nucleic acid instead of standard infectivity tests (see 7.). Another study of the same cohort observed that the risk of developing AIDS correlated with the frequency of receptive anal intercourse prior to and after HIV infection 280, which correlates directly with the use of nitrite vasodilaters 26,10°’104,130,281 (see 3.). Thus, in male homosexuals at risk for AIDS, AIDS often precedes infection by HIV, not vice versa. Since LÆKNANEMINN 116 1. tbl. 1997, 50. árg.
Qupperneq 1
Qupperneq 2
Qupperneq 3
Qupperneq 4
Qupperneq 5
Qupperneq 6
Qupperneq 7
Qupperneq 8
Qupperneq 9
Qupperneq 10
Qupperneq 11
Qupperneq 12
Qupperneq 13
Qupperneq 14
Qupperneq 15
Qupperneq 16
Qupperneq 17
Qupperneq 18
Qupperneq 19
Qupperneq 20
Qupperneq 21
Qupperneq 22
Qupperneq 23
Qupperneq 24
Qupperneq 25
Qupperneq 26
Qupperneq 27
Qupperneq 28
Qupperneq 29
Qupperneq 30
Qupperneq 31
Qupperneq 32
Qupperneq 33
Qupperneq 34
Qupperneq 35
Qupperneq 36
Qupperneq 37
Qupperneq 38
Qupperneq 39
Qupperneq 40
Qupperneq 41
Qupperneq 42
Qupperneq 43
Qupperneq 44
Qupperneq 45
Qupperneq 46
Qupperneq 47
Qupperneq 48
Qupperneq 49
Qupperneq 50
Qupperneq 51
Qupperneq 52
Qupperneq 53
Qupperneq 54
Qupperneq 55
Qupperneq 56
Qupperneq 57
Qupperneq 58
Qupperneq 59
Qupperneq 60
Qupperneq 61
Qupperneq 62
Qupperneq 63
Qupperneq 64
Qupperneq 65
Qupperneq 66
Qupperneq 67
Qupperneq 68
Qupperneq 69
Qupperneq 70
Qupperneq 71
Qupperneq 72
Qupperneq 73
Qupperneq 74
Qupperneq 75
Qupperneq 76
Qupperneq 77
Qupperneq 78
Qupperneq 79
Qupperneq 80
Qupperneq 81
Qupperneq 82
Qupperneq 83
Qupperneq 84
Qupperneq 85
Qupperneq 86
Qupperneq 87
Qupperneq 88
Qupperneq 89
Qupperneq 90
Qupperneq 91
Qupperneq 92
Qupperneq 93
Qupperneq 94
Qupperneq 95
Qupperneq 96
Qupperneq 97
Qupperneq 98
Qupperneq 99
Qupperneq 100
Qupperneq 101
Qupperneq 102
Qupperneq 103
Qupperneq 104
Qupperneq 105
Qupperneq 106
Qupperneq 107
Qupperneq 108
Qupperneq 109
Qupperneq 110
Qupperneq 111
Qupperneq 112
Qupperneq 113
Qupperneq 114
Qupperneq 115
Qupperneq 116
Qupperneq 117
Qupperneq 118
Qupperneq 119
Qupperneq 120
Qupperneq 121
Qupperneq 122
Qupperneq 123
Qupperneq 124
Qupperneq 125
Qupperneq 126
Qupperneq 127
Qupperneq 128
Qupperneq 129
Qupperneq 130
Qupperneq 131
Qupperneq 132
Qupperneq 133
Qupperneq 134
Qupperneq 135
Qupperneq 136
Qupperneq 137
Qupperneq 138
Qupperneq 139
Qupperneq 140

x

Læknaneminn

Direct Links

Hvis du vil linke til denne avis/magasin, skal du bruge disse links:

Link til denne avis/magasin: Læknaneminn
https://timarit.is/publication/1885

Link til dette eksemplar:

Link til denne side:

Link til denne artikel:

Venligst ikke link direkte til billeder eller PDfs på Timarit.is, da sådanne webadresser kan ændres uden advarsel. Brug venligst de angivne webadresser for at linke til sitet.